通过免疫接种控制乙型肝炎感染的进展
Progress on the control of hepatitis B infection through immunisation.
作者信息
Kane M A
机构信息
World Health Organisation, Geneva, Switzerland.
出版信息
Gut. 1993;34(2 Suppl):S10-2. doi: 10.1136/gut.34.2_suppl.s10.
Abstract
Hepatitis B virus (HBV) infection and its sequelae, one of the major diseases of mankind, is now a disease preventable by vaccine. During the last few years, the price of these vaccines has fallen to the point where widespread use in infant immunisation programmes is feasible. This paper reports the great progress that has been made in the control of HBV infection and describes the targets that must be met if HBV control on a global basis is to be achieved.
摘要
乙型肝炎病毒（HBV）感染及其后遗症是人类的主要疾病之一，现在是一种可用疫苗预防的疾病。在过去几年中，这些疫苗的价格已降至可在婴儿免疫计划中广泛使用的程度。本文报告了在控制HBV感染方面取得的巨大进展，并描述了要在全球范围内实现HBV控制必须达到的目标。
相似文献
1
Progress on the control of hepatitis B infection through immunisation.通过免疫接种控制乙型肝炎感染的进展
Gut. 1993;34(2 Suppl):S10-2. doi: 10.1136/gut.34.2_suppl.s10.
2
Cost-effectiveness of hepatitis-B vaccine in Greece. A country of intermediate HBV endemicity.希腊乙型肝炎疫苗的成本效益。一个乙型肝炎病毒中等流行率的国家。
Int J Technol Assess Health Care. 1991;7(3):256-62. doi: 10.1017/s026646230000564x.
3
Hepatitis B vaccination.乙肝疫苗接种
J Virol Methods. 1985 Apr;10(4):327-31. doi: 10.1016/0166-0934(85)90049-7.
4
Cost-benefit analysis of hepatitis-B vaccination. A computerized decision model for Spain.乙型肝炎疫苗接种的成本效益分析。西班牙的计算机化决策模型。
Int J Technol Assess Health Care. 1991;7(3):379-402. doi: 10.1017/s0266462300005754.
5
Cost-effectiveness analysis of hepatitis B vaccination strategies in Catalonia, Spain.西班牙加泰罗尼亚地区乙肝疫苗接种策略的成本效益分析
Pharmacoeconomics. 1995 May;7(5):428-43. doi: 10.2165/00019053-199507050-00007.
6
IHF proposes hepatitis A vaccine immunogenicity and efficacy trials.国际健康基金会提议进行甲型肝炎疫苗免疫原性和有效性试验。
S D Nurse. 1990 Nov;32(4):21.
7
Hepatitis B immunisation.乙型肝炎免疫接种
N Z Med J. 1988 Aug 10;101(851):518-9.
8
Hepatitis B virus and the control of hepatocellular carcinoma.乙型肝炎病毒与肝细胞癌的控制
IARC Sci Publ. 1984(63):243-61.
9
Hepatitis B vaccination in children: five year booster study.儿童乙肝疫苗接种：五年加强免疫研究。
N Z Med J. 1992 Aug 26;105(940):336-8.
10
Hepatitis B vaccines.乙肝疫苗
Prog Liver Dis. 1990;9:405-42.
引用本文的文献
1
Effect of hepatitis B vaccination on HBV-infection among school children in Yaounde; ten years after the introduction of HBV vaccine into routine Immunization Program in Cameroon.乙型肝炎疫苗接种对雅温得地区学龄儿童乙型肝炎病毒感染的影响；在喀麦隆将乙型肝炎疫苗纳入常规免疫规划十年来。
Pan Afr Med J. 2024 Apr 5;47:169. doi: 10.11604/pamj.2024.47.169.40369. eCollection 2024.
2
Hepatitis B virus (HBV) infection amongst children in Senegal: current prevalence and seroprotection level.塞内加尔儿童中的乙型肝炎病毒（HBV）感染：当前流行率和血清保护水平
Pan Afr Med J. 2019 Mar 25;32:140. doi: 10.11604/pamj.2019.32.140.14485. eCollection 2019.
3
Lack of an effect of human immunodeficiency virus coinfection on the pharmacokinetics of entecavir in hepatitis B virus-infected patients.人类免疫缺陷病毒合并感染对乙型肝炎病毒感染患者恩替卡韦药代动力学无影响。
Antimicrob Agents Chemother. 2008 Aug;52(8):2836-41. doi: 10.1128/AAC.01366-07. Epub 2008 Apr 7.
4
Review of 336 patients with hepatocellular carcinoma at Songklanagarind Hospital.宋卡王子大学医学院素叻他尼医院336例肝细胞癌患者的回顾。
World J Gastroenterol. 2000 Jun;6(3):339-343. doi: 10.3748/wjg.v6.i3.339.
5
Ante-natal screening for hepatitis B surface antigen: an appraisal of its value in a low prevalence area.乙型肝炎表面抗原的产前筛查：对其在低流行地区价值的评估。
Epidemiol Infect. 1996 Aug;117(1):121-31. doi: 10.1017/s0950268800001217.
6
Hepatitis in nursing homes. Incidence and management strategies.养老院中的肝炎。发病率及管理策略。
Drugs Aging. 1994 Aug;5(2):96-101. doi: 10.2165/00002512-199405020-00003.
Zotero 插件